A Phase 1, Randomized, Single Center, Open Label, 2 Sequence, 2 Period, Crossover Study to Evaluate the Effect of Food on the Single Dose Pharmacokinetics of Telotristat Etiprate (LX1606 Hippurate) in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Sep 2014
Price : $35 *
At a glance
- Drugs Telotristat etiprate (Primary)
- Indications Malignant carcinoid syndrome
- Focus Pharmacokinetics
- Sponsors Lexicon Pharmaceuticals
- 05 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.